Nov 3 2018

Targeting Cancer: 7th Annual Update in Oncology Pharmacy

November 3, 2018

8:00 AM - 2:30 PM

Location

UIC College of Pharmacy

Address

Chicago Room 134-1, Rockford Room E230, Chicago, IL 60612

Cost

$40

Calendar

Download iCal File

Targeting Cancer: 7th Annual Update in Oncology Pharmacy
A Knowledge-Based Symposium
Saturday, November 3, 2018
9:00am - 2:30pm

Click Here to View the Agenda for Oncology Symposium 2018

Click Here for Registration

Live Symposium:
UIC College of Pharmacy (Chicago)
833 S. Wood Street, Room 134-1
Chicago, Illinois 60612

Live Broadcast:
UIC College of Pharmacy (Rockford)
1601 Parkview Ave, Room E230
Rockford, Illinois 61107

Program Chair:
Sandra Cuellar, PharmD, BCOP
Director, Specialty Residency in Oncology
Clinical Assistant Professor, Department of Pharmacy Practice
Clinical Pharmacist, Oncology
University of Illinois at Chicago, College of Pharmacy
Chicago, Illinois

Target Audience:
Pharmacists and other healthcare professionals who care for patients with cancer.

Program Description:
New developments in pharmacotherapy and a better understanding of cancer origins continue to revolutionize the treatment of patients with cancer and challenge the clinical pharmacist to stay abreast of emerging therapies with novel toxicities. This conference will examine approaches to the treatment of hematologic malignancies and provide an overview of new drug therapies. Highlighted topics will include a review of PARP inhibitors in ovarian cancer, anti-infective therapies, reimbursement, and updates in breast care management. In addition, the symposium will include a session on treatment advances in acute myeloid leukemia.

Registration Information:
Registration Fee: $40.00
Registration fee includes 3.75 contact hours of continuing pharmacy education credit, electronic handout, continental breakfast, lunch, and parking. Space is limited and early registration is encouraged.

Registration Deadline: Friday, October 26, 2018

Please Note: All audience response questions, such as pre- and post-tests and active learning questions, will be conducted via the internet. Attendees must bring a smartphone, tablet, or laptop to this conference in order to participate in these activities and earn CE credits.

Exhibitors: Agios Pharmaceuticals, Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Celgene, Eli Lilly and Company, Jazz Pharmaceuticals, Kyowa Kirin, Merck, Novartis, Onyx, Taiho Oncology, and Tesaro Biopharmaceutical

Agenda

8:00am – 9:00am	Registration, Exhibits, and Continental Breakfast
9:00am – 9:15am	Welcome *Sandra Cuellar, PharmD, BCOP* Director, Specialty Residency in Oncology Clinical Assistant Professor Clinical Pharmacist, Oncology University of Illinois at Chicago College of Pharmacy
9:15am – 10:00am	Updates in Breast Cancer Management: A Focus on 2018 *Laura Boehnke Michaud, PharmD, BCOP, FASHP, CMQ* UAN # 0016-0000-18-017-L01-P 0.75 contact hour Learning Objectives: Discuss the new and old staging systems for breast cancer and how these may impact application of clinical trial data Describe new therapies for early stage and metastatic breast cancer and how they integrate into standard of care guidelines Summarize investigational approaches to breast cancer treatment on the horizon and how these may impact the standard of care
10:00am - 10:45am	Treatment Advances in Acute Myeloid Leukemia Shilpa Paul, PharmD, BCOP UAN # 0016-0000-18-018-L01-P 0.75 contact hour Learning Objectives: Discuss newly approved and emerging treatments for Acute Myeloid Leukemia (AML) Describe the benefits and limitations of each treatment as well as their place in AML therapy Identify adverse effects associated with each treatment and indicate strategies for proper management
10:45am – 11:00am	Break
11:00am – 11:45am	Reimbursement: Oncology Updates *Timothy Tyler, PharmD, FCSHP, FHOPA* UAN # 0016-0000-18-019-L04-P 0.75 contact hour Learning Objectives: Describe recent federal government changes in reimbursement for cancer care that primarily affect hospital practice Discuss the recent reimbursement changes in both 340B and oncology-related biosimilars Review the differences between reimbursements for intravenous products versus oral products
11:45am – 1:00pm	Luncheon, Exhibits, and Networking
1:00pm – 1:45pm	An Update on Anti-Infective Therapies *Eric Wenzler, PharmD, BCPS, AAHIVP* UAN # 0016-0000-18-020-L01-P 0.75 contact hour Learning Objectives: Review newly approved antibacterial agents and discuss their potential place in therapy Discuss newly approved antifungal agents and review their potential place in therapy Recognize how newly approved antiviral agents could change prophylaxis and treatment of Cytomegalovirus (CMV)
1:45pm – 2:30pm	Role of PARP Inhibitors in Ovarian Cancer Po-Hung Lin, PharmD UAN # 0016-0000-18-021-L01-P 0.75 contact hour Learning Objectives: Review the mechanism of action and pharmacology for PARP inhibitors Discuss the role of PARP inhibitors in ovarian cancer Describe FDA approved PARP inhibitors in ovarian cancer
2:30pm	Closing Remarks Sandra Cuellar, PharmD, BCOP

Accreditation: The University of Illinois at Chicago College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Pharmacists may earn up to a total of 3.75 contact hours (0.375 CEUs), as each session is accredited for 0.75 contact hours. Attendance at the entire knowledge-based activity, completion of the evaluation form, and submission of NABP eProfile ID and MMDD are prerequisites for receiving continuing pharmacy education credit(s) at each session. All ACPE credit awarded to participants must be uploaded to CPE Monitor™ within 30 days of the activity date, so pharmacists are required to provide their e-Profile ID and date of birth (MMDD) at the time of the activity. Please contact pharmce@uic.edu if you do not see activity information listed within 30 days. For more information and to set up your e-Profile visit: www.MyCPEmonitor.net.